Peter Chang

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

Gavin Giovannoni, Stuart D. Cook, Kottil Rammohan et al. · New England Journal of Medicine · 2010 · 1K citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +16

Beyond the Imitation Game: Quantifying and extrapolating the capabilities of language models

Aarohi Srivastava, Abhinav Rastogi, Abhishek S. Rao et al. · arXiv (Cornell University) · 2022 · 548 citations · Full text

Computing, Computer Science, Linguistics +14

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

Daniel D. Mikol, Frederik Barkhof, Peter Chang et al. · The Lancet Neurology · 2008 · 484 citations

Life Sciences, Neurology, Pharmacotherapy +13

Five-year Analysis of a Multi-institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry

Phillip M. Pierorazio, Michael H. Johnson, Mark W. Ball et al. · European Urology · 2015 · 398 citations

Medicine, Internal Medicine, Nephrology +14

A Multicenter Prospective Study of 3,110 Consecutive Cases of Elective Epinephrine Use in the Fingers and Hand: The Dalhousie Project Clinical Phase

Donald H. Lalonde, Michael Bell, Paul Benoı̂t et al. · The Journal Of Hand Surgery · 2005 · 394 citations

Medicine, Pharmacology, Clinical Pharmacology +4